Gain Therapeutics GANX Insider Ownership

NASDAQ GANX
$1.16 -0.03 (-2.49%)
As of: Oct 21, 2026 · 11:39 AM EDT

Insider Holdings by Owner

625.90K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.896%
■0% pp QoQ
Shares Held by Insiders
384.03K
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
42.88Mn
42,879,541 shares
Direct Holdings
384.03K
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
6
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

In the last 12 months, insiders at Gain Therapeutics neither bought nor sold shares on the open market.

Form 4 Holdings

Insiders Holding GANX

Insiders 6
Shares held 625.90K
Of outstanding 1.46%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Eric I Richman Chief Executive Officer 507,358 0 507,358 81.1% 01 Jul, 2024
2 Khalid Islam Executive Chairman 50,000 0 50,000 8.0% 12 Aug, 2024
3 Jeffrey Scott Riley Director 30,000 0 30,000 4.8% 01 Apr, 2024
4 Matthias Alder Chief Executive Officer 21,140 0 21,140 3.4% 28 Mar, 2024
5 Gene Mack Cfo And Interim Ceo 14,400 0 14,400 2.3% 12 Aug, 2024
6 Salvatore Calabrese Chief Financial Officer 3,000 0 3,000 0.5% 23 May, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

86 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
15 Jul, 2026 Gwen A Melincoff Director Acquired A 25,000 $0.00 $0 25,000 Direct
15 Jul, 2026 Khalid Islam Director Acquired A 25,000 $0.00 $0 25,000 Direct
15 Jul, 2026 Dov A Md Goldstein Director Acquired A 25,000 $0.00 $0 25,000 Direct
15 Jul, 2026 Hans Peter Hasler Director Acquired A 25,000 $0.00 $0 25,000 Direct
15 Jul, 2026 Claude Nicaise Director Acquired A 25,000 $0.00 $0 25,000 Direct
15 Jul, 2026 Jeffrey Scott Riley Director Acquired A 25,000 $0.00 $0 25,000 Direct
24 Mar, 2026 Gene Mack Ceo, President Acquired A 200,000 $0.00 $0 200,000 Direct
24 Mar, 2026 Gianluca Fuggetta See Remark Acquired A 50,000 $0.00 $0 50,000 Direct
24 Jun, 2025 Gwen A Melincoff Director Acquired A 15,000 $0.00 $0 15,000 Direct
24 Jun, 2025 Claude Nicaise Director Acquired A 15,000 $0.00 $0 15,000 Direct
24 Jun, 2025 Khalid Islam Director Acquired A 15,000 $0.00 $0 15,000 Direct
24 Jun, 2025 Jeffrey Scott Riley Director Acquired A 15,000 $0.00 $0 15,000 Direct
24 Jun, 2025 Dov A Md Goldstein Director Acquired A 15,000 $0.00 $0 15,000 Direct
24 Jun, 2025 Eric I Richman Director Acquired A 15,000 $0.00 $0 15,000 Direct
24 Jun, 2025 Hans Peter Hasler Director Acquired A 15,000 $0.00 $0 15,000 Direct
20 Mar, 2025 Gianluca Fuggetta See Remark Acquired A 50,000 $0.00 $0 50,000 Direct
20 Mar, 2025 Gene Mack Ceo, President Acquired A 200,000 $0.00 $0 200,000 Direct
06 Jan, 2025 Gene Mack Ceo, President Acquired A 271,325 $0.00 $0 271,325 Direct
09 Aug, 2024 Gene Mack Cfo And Interim Ceo Acquired P 14,400 $1.01 $14.54K 14,400 Direct
09 Aug, 2024 Khalid Islam Executive Chairman Acquired P 50,000 $1.00 $49.94K 50,000 Direct